View More Recent Stories

Mar 28, 2019 04:15PM Neurocrine Biosciences and Voyager Therapeutics Announce Publication of Phase 1b Trial Results of VY-AADC for Parkinson’s Disease in the Annals of Neurology
Feb 26, 2019 04:05PM Voyager Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Corporate Highlights
Feb 22, 2019 08:01AM AbbVie (ABBV), Voyager Therapeutics (VYGR) Enter Pact to Develop Vectorized Antibodies to Treat Parkinson's Disease and Other Synucleinopathies
Feb 22, 2019 08:00AM AbbVie and Voyager Therapeutics Announce Collaboration to Develop Vectorized Antibodies to Treat Parkinson's Disease and Other Synucleinopathies
Feb 22, 2019 08:00AM Voyager Therapeutics and AbbVie Announce Collaboration to Develop Vectorized Antibodies to Treat Parkinson’s Disease and Other Synucleinopathies
Feb 20, 2018 07:03AM Voyager Therapeutics (VYGR), AbbVie (ABBV) Enter Pact to Develop Potential New Treatments for Alzheimer’s Disease and Other Tau-Related Neurodegenerative Diseases
Feb 20, 2018 07:00AM AbbVie and Voyager Therapeutics Announce Global Strategic Collaboration to Develop Potential New Treatments for Alzheimer's Disease and Other Tau-Related Neurodegenerative Diseases
Feb 20, 2018 07:00AM Voyager Therapeutics and AbbVie Announce Global Strategic Collaboration to Develop Potential New Treatments for Alzheimer’s Disease and Other Tau-Related Neurodegenerative Diseases
Apr 25, 2016 11:12AM Voyager Therapeutics (Nasdaq: VYGR) to Ring The Nasdaq Stock Market Opening Bell
View More Recent Stories